Covered recipient · General Payments record
WENDY MARIE CLARK
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2022–2024
$990.73
- Reported across 49 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $623.59 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $315.40 | 21 |
| Exact Sciences Corporation | $148.20 | 5 |
| Axsome Therapeutics, Inc. | $41.20 | 2 |
| Philips Electronics North America Corporation | $28.30 | 2 |
| E.R. Squibb & Sons, L.L.C. | $27.70 | 1 |
| Alkermes, Inc. | $24.04 | 1 |
| Neurocrine BioSciences, Inc. | $23.56 | 1 |
| Merck Sharp & Dohme Corporation | $15.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.04 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106924564 | CMS |
| ABBVIE INC. | $20.57 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106924566 | CMS |
| ABBVIE INC. | $19.48 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106924568 | CMS |
| ABBVIE INC. | $18.67 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106924570 | CMS |
| ABBVIE INC. | $27.98 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106924572 | CMS |
| ABBVIE INC. | $32.97 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106924574 | CMS |
| ABBVIE INC. | $5.19 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106924576 | CMS |
| ABBVIE INC. | $6.27 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106924578 | CMS |
| ABBVIE INC. | $13.56 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106924580 | CMS |
| ABBVIE INC. | $5.19 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106924582 | CMS |
| ABBVIE INC. | $3.81 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106924584 | CMS |
| ABBVIE INC. | $19.07 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106924586 | CMS |
| ABBVIE INC. | $17.99 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106924588 | CMS |
| ABBVIE INC. | $11.20 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106924590 | CMS |
| ABBVIE INC. | $32.08 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106924592 | CMS |
| ABBVIE INC. | $5.34 | 06/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106924594 | CMS |
| ABBVIE INC. | $4.81 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106924596 | CMS |
| ABBVIE INC. | $5.78 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106924598 | CMS |
| ABBVIE INC. | $14.36 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106924600 | CMS |
| ABBVIE INC. | $33.00 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106924602 | CMS |
| ABBVIE INC. | $10.04 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106924604 | CMS |
| Alkermes, Inc. | $24.04 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120480894 | CMS |
| Axsome Therapeutics, Inc. | $16.96 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148419157 | CMS |
| Axsome Therapeutics, Inc. | $24.24 | 04/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148419159 | CMS |
| E.R. Squibb & Sons, L.L.C. | $27.70 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101330768 | CMS |
| Exact Sciences Corporation | $24.50 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114527389 | CMS |
| Exact Sciences Corporation | $31.16 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114527393 | CMS |
| Exact Sciences Corporation | $29.04 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114527398 | CMS |
| Exact Sciences Corporation | $30.15 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114527401 | CMS |
| Exact Sciences Corporation | $33.35 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114527405 | CMS |
| Merck Sharp & Dohme LLC | $15.19 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141955947 | CMS |
| Neurocrine Biosciences, Inc. | $23.56 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150961380 | CMS |
| Philips North America LLC | $13.31 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146854862 | CMS |
| Philips North America LLC | $14.99 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146854864 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.